期刊文献+

念珠菌性阴道炎患者的辅助治疗 被引量:3

Adjuvant management of patients with candida vulvovaginitis
下载PDF
导出
摘要 目的报道80例念珠菌性阴道炎患者的辅助治疗。方法应用的方法为心理疏导、指导用药、皮肤护理和健康教育。结果 72例(90.00%)经1个疗程后痊愈,6例(7.50%)经2个疗程后痊愈,2例(2.50%)转变为顽固性念珠菌性阴道炎。结论心理疏导、指导用药、皮肤护理和健康教育对念珠菌性阴道炎患者的治疗有益。 Objective To report 80 cases of candida vulvovaginitis received adjuvant management. Methods The adjuvant management is including methods of psychological counseling, guidance, medication and heahh education. Results Seventy-two ca-ses (90.00%) recovered after a course of treatment, 6 cases (7.50%) were cured after two courses and 2 cases (2.50%) changed into the refractory candida vulvovaginitis. Conclusion Psychological counseling, guidance, medication, skin care and heahh education are benefit for the treatment of patients with eandida vulvovaginitis.
出处 《中国真菌学杂志》 2012年第6期365-366,共2页 Chinese Journal of Mycology
关键词 念珠菌 念珠菌性阴道炎 患者 辅助治疗 Candida spp. candida vulvovaginitis patient adjuvant therapy
  • 相关文献

参考文献6

二级参考文献40

  • 1张有江,张秀菊,姜春云,杨继勇.PCR指纹图技术鉴定临床常见酵母菌的探讨[J].中华医院感染学杂志,2004,14(4):377-380. 被引量:2
  • 2Bennet JE.Echinocandins for candidemia in adults without neu-tropenia[J].N Engl J Med,2006,355(11):1154-1159. 被引量:1
  • 3Pfaller MA,Pappas PG,Wingard JR.Invasive fungal patho-gens:current epidemiological trends[J].Clin Infect Dis,2006,43(Suppl 1):S3-14. 被引量:1
  • 4Pfaller MA,Diekema DJ.Rare and emerging opportunistic fun-gal pathogens:concern for resistance beyond Candida albicansand Aspergillus fumigatus[J].J Clin Microbiol,2004,42(10):4419-4431. 被引量:1
  • 5Segal BH,Almyroudis NG,Battiwalla M,et al.Prevention andearly treatment of invasive fungal infection in patients with canc-er and neutropenia and in stem cell transplant recipients in theera of newer broad-spectrum antifungal agents and diagnostic ad-juncts[J].Clin Infect Dis,2007,44(3):402-409. 被引量:1
  • 6Cornely OA,Maertens J,Bresnik M,et al.AmBiLoad Trial StudyGroup.Liposomal amphotericin B as initial therapy for invasivemold infection:a randomized trial comparing a high-loading doseregimen with standard dosing(AmBiLoad Trial)[J].Clin InfectDis,2007,44(10):1289-1297. 被引量:1
  • 7Johnson LB,Kauffman CA.Voriconazole:a new triazole antifun-gal agent[J].Clin Infect Dis,2003,36(5):630-637. 被引量:1
  • 8Dannaoui E,Meletiadis J,Mouton JW,et al.In vitro susceptibili-ties of zygomycetes to conventional and new antifungals[J].JAntimicrob Chemother,2003,51(1):45-52. 被引量:1
  • 9Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole ver-sus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(8):408-415. 被引量:1
  • 10Perfect JR,Marr KA,Walsh TJ,et al.Voriconazole treatment forless common,emerging,or refractory fungal infections[J].ClinInfect Dis,2003,36(9):1122-1131. 被引量:1

共引文献33

同被引文献20

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部